These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 34944546)

  • 1. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
    Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
    Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
    Roy S; Dhaneshwar S
    World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009-2020.
    Darb Emamie A; Rajabpour M; Ghanavati R; Asadolahi P; Farzi S; Sobouti B; Darbandi A
    J Appl Microbiol; 2021 Jun; 130(6):1823-1838. PubMed ID: 33098703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A; Zielińska M; Storr M; Fichna J
    Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
    Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
    Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Chlebicz-Wójcik A; Śliżewska K
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Oka A; Sartor RB
    Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.
    Markowiak P; Śliżewska K
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28914794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms.
    Li C; Niu Z; Zou M; Liu S; Wang M; Gu X; Lu H; Tian H; Jha R
    J Dairy Sci; 2020 Jul; 103(7):5816-5829. PubMed ID: 32418689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era.
    Ferrarese R; Ceresola ER; Preti A; Canducci F
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7588-7605. PubMed ID: 30468509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis.
    Jadhav A; Jagtap S; Vyavahare S; Sharbidre A; Kunchiraman B
    Front Cell Infect Microbiol; 2023; 13():1268041. PubMed ID: 38145046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Improve Health with Biological Agents-Narrative Review.
    Zawistowska-Rojek A; Tyski S
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Synbiotics for Ulcerative Colitis Treatment.
    Roselli M; Finamore A
    Curr Clin Pharmacol; 2020; 15(3):174-182. PubMed ID: 31878863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome.
    Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H
    Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.